Popular Information - Toyota's second U-turn

Key phrases

Older messages

UPDATES: Koch exits, DeSantis responds

Friday, April 22, 2022

For the last five weeks, Popular Information has reported extensively on Koch Industries, the corporation owned by right-wing billionaire Charles Koch, and its decision to continue business in Russia.

Inside the "dangerous" math textbooks DeSantis claims would "indoctrinate students"

Thursday, April 21, 2022

On April 15, the Florida Department of Education issued a dramatic press release: "Florida Rejects Publishers' Attempts to Indoctrinate Students." In the release, Florida Commissioner of

Passing the mic [CORRECTED]

Wednesday, April 20, 2022

Apologies for the multiple emails this morning. Due to a technical error, the previous version did not have a link to the discussion thread. — J… ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Passing the mic

Wednesday, April 20, 2022

So far this month, Popular Information exposed the inner workings of Charles Koch's non-profit network (prompting an avalanche of attacks from Koch-funded entities), revealed that the consulting

Inflation profiteering

Tuesday, April 19, 2022

There is no single cause for inflation, which reached an annual rate of 8.5% in March. That's the fastest increase in prices since 1981. There are continuing problems with supply chains, rising

You Might Also Like

Full-crime job

Friday, April 26, 2024

Lawyers for Trump argued before SCOTUS that the president has "total immunity" ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

All of My Friends Have These Sweatpant Jeans

Friday, April 26, 2024

Here's What You Missed on the Strategist The Strategist Every product is independently selected by editors. If you buy something through our links, New York may earn an affiliate commission. All of

🌈 Live a bold & bright life

Friday, April 26, 2024

Introducing our theme for May plus fun stuff to read, watch, and click on curated by CreativeMornings HQ. April 25, 2024 Open in new tab Did a friend forward this? Subscribe today! Speech bubble logo

🕐 Time Is Running Out: Your $99 Offer Expires In 48 Hours

Thursday, April 25, 2024

This advisory has returned a massive 838% since inception compared to the 273% return from the S&P 500 Final 48 Hours Fellow Investor, We recently sent you an exclusive offer to try our flagship

The Professor Protesting Columbia’s Own Students

Thursday, April 25, 2024

Columns and commentary on news, politics, business, and technology from the Intelligencer team. Intelligencer THURSDAY, APRIL 25 The Professor Protesting Columbia's Own Students Shai Davidai, a

Before you lose your phone ...

Thursday, April 25, 2024

Do these things now ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Friday Briefing: Supreme Court hears Trump immunity case

Thursday, April 25, 2024

Also, more bodies found in a Gazan mass grave. View in browser|nytimes.com Continue reading the main story Ad Morning Briefing: Asia Pacific Edition April 26, 2024 Author Headshot By Amelia Nierenberg

Microsoft results beat quarterly expectations as profits rise 20% to nearly $22B

Thursday, April 25, 2024

Breaking News from GeekWire GeekWire.com | View in browser BREAKING NEWS Microsoft posted a 17% increase in revenue, to $61.9 billion, with $21.9 billion in profits, up 20%, and earnings of $2.94 per

The Dark Side of Immune

Thursday, April 25, 2024

SCOTUS and Why It's Good to be the King ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Techie-turned-lawmaker uses Microsoft chops as state senator | ‘Acquired’ podcast hosts raising fund

Thursday, April 25, 2024

Amazon to stream Seattle Kraken games | Impinj stock soars | 'Good to Go!' scam warning ADVERTISEMENT GeekWire SPONSOR MESSAGE: Science Firsthand: Learn how Bristol Myers Squibb unlocked the